JVL Associates’s Merck MRK Stock Holding History

JVL Associates’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$278K	Buy	1,910 +301	+19%	+$41.6K	0.08%	65
2026 Q2	$207K	Buy	+1,609	New	+$188K	0.06%	77

Other funds holding MRK

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

JVL Associates's MRK Position: Q3 2026 in Review

JVL Associates increased its Merck (MRK) stake by 19% in Q3 2026, buying an estimated $41.6K and bringing the position to 1,910 shares worth $278K. The position accounts for 0.08% of the portfolio, ranked #65.

JVL Associates first reported a position in MRK in Q2 2026 and has held it in 2 quarters since. 2,771 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

JVL Associates held 1,910 shares of Merck worth $278K as of Q3 2026.
JVL Associates bought 301 Merck shares in Q3 2026, an estimated $41.6K.
Merck made up 0.08% of JVL Associates's portfolio in Q3 2026, its #65 holding.
JVL Associates first reported a position in Merck in Q2 2026 and has held it in 2 quarters since.
2,771 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on JVL Associates's 13F filing for Q3 2026, filed 9 Oct 2026.